Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.12 is in line with its 3-year average of 0.12, near the low end of its 3-year range (0.00–0.74).
As of the fiscal period ended Tuesday, June 30, 2026. 19.99% below its 12-month average of 0.15.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.12.
DEBT TO EQUITY RATIO
0.12
DEBT TO EQUITY RATIO AVG TTM
0.15
DEBT TO EQUITY RATIO AVG 3Y
0.18
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-19.99%
CURRENT VS 3Y AVG
-33.40%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-82.56%
vs the sector median at left
Shoulder Innovations, Inc.
Market Cap
$376.61M
Debt to Equity Ratio
0.12
TTM Avg
0.15
3Y Avg
0.18
5Y Avg
N/A
Market Cap
$45.05M
Debt to Equity Ratio
N/A
TTM Avg
1.49
3Y Avg
1.10
5Y Avg
0.74
Market Cap
$1.14B
Debt to Equity Ratio
0.79
TTM Avg
0.91
3Y Avg
0.80
5Y Avg
0.56
Market Cap
$1.91B
Debt to Equity Ratio
1.71
TTM Avg
1.50
3Y Avg
1.07
5Y Avg
0.87
Market Cap
$2.99B
Debt to Equity Ratio
1.67
TTM Avg
1.63
3Y Avg
1.85
5Y Avg
1.39
Market Cap
$5.10B
Debt to Equity Ratio
0.49
TTM Avg
0.57
3Y Avg
0.53
5Y Avg
0.48
Market Cap
$5.59B
Debt to Equity Ratio
0.80
TTM Avg
0.31
3Y Avg
0.29
5Y Avg
0.31
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | 0.12 | 0.15 | 0.18 | N/A |
| NRC Health (NRC)vs › | $463.35M | 13.75 | 3.86 | 2.21 | 1.62 |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A | 1.49 | 1.10 | 0.74 |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 0.79 | 0.91 | 0.80 | 0.56 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 1.71 | 1.50 | 1.07 | 0.87 |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 1.67 | 1.63 | 1.85 | 1.39 |
| Doximity, Inc. (DOCS)vs › | $4.88B | 0.01 | 0.01 | 0.02 | 0.01 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 0.49 | 0.57 | 0.53 | 0.48 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | 0.80 | 0.31 | 0.29 | 0.31 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 4.77 | 1.04 | 0.53 | 0.36 |
Debt/Equity
0.12
Current Ratio
10.71
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.12 |
| 2026-03-31 | 0.11 |
| 2025-12-31 | 0.11 |
| 2025-09-30 | 0.10 |
| 2025-06-30 | 0.31 |
| 2025-03-31 | 0.42 |
| 2024-12-31 | 0.74 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.42 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
